Comparison of TOFscan and TOF-Watch SX in Pediatric Neuromuscular Function Recovery

Comparison of TOFscan and TOF-Watch SX for monitoring of neuromuscular blockade function in children

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Neuromuscular Blockade

Age range

Up to 12 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Seoul National University Hospital

Seoul, 03080, South Korea

About this study

TOF ratio of TOFscan when TOF-Watch SX shows TOF ratio 0.7 with rocuronium in children during general anesthesia

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patients need neuromuscular blockade

Exclusion criteria

contraindication of rocuronium

Treatment and study plan

TOFscan

Device

comparison of TOFscan over TOF-Watch SX

Primary outcomes

TOF ratio of TOFscan

Time frame: intraoperative during anesthesia

value of TOF ratio of TOFscan at TOF ratio 0.7 of TOF-Watch SX during neuromuscular function recovery period

Sponsors and collaborators

Lead sponsor

Seoul National University Hospital

Other

Registry information

Official study title

Comparison of TOFscan and TOF-Watch SX in Children

Important dates

Study start: 2019
Primary completion: 2020
Study completion: 2020
First posted: Dec 14, 2018
Registry last updated: Apr 16, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed